Leading the list is Anipryl
(selegiline HCL or L-deprenyl).
The drug Anipryl
was approved by the FDA as a treatment for canine cognitive dysfunction and is sometimes effective for dogs, but it hasn't been approved for feline use.
Potential Treatments: Mitotane, ketoconazole, adrenalectomy, Anipryl
, and radiation therapy of pituitary.
is approved for the treatment of canine age-related cognitive disorder, and Clomipramine is approved for the treatment of separation anxiety.
This falling out began in 1998 when DAHI's parent company announced that the FDA had approved the drug Anipryl
when used to treat canine cognitive dysfunction.
Made by Pfizer, Anipryl
has worked (to some extent) in about 75% of dogs with this problem.
Also on January 5 the FDA gave the thumbs up to Pfizer's Anipryl
, the first drug approved for doggie Alzheimer's.
by Pfizer, taken daily, helps reorient older dogs diagnosed with Cognituve Dysfunction Syndrome, characterized by disorientation or confusion, not recognizing owners, sleep disorders and house-training problems.
Do not combine DLPA with MAOI drugs like Anipryl
, used to treat Cushing's Disease and canine cognitive dysfunction, or amitraz, an ingredient in tick collars.
Veterinarians may prescribe Anipryl
(selegiline), the first FDA-approved drug to control the signs of signs of canine CDS.
It could include aspirin, anipryl
for cognitive dysfunction or anti-seizure medications.
For example, products containing amitraz (such as Certifect) should not be used on "medicated" dogs, such as those with diabetes or heart problems; amitraz, a monoamine oxidase inhibitor (MAOI), can be dangerous when combined with antidepressants (such as those used to treat separation anxiety), Anipryl
(used for canine cognitive dysfunction and Cushing's disease), and DL-Phenylalanine (DLPA), used to treat chronic pain.